The effects of halothane and methoxyflurane metabolites on lipolysis in vitro.
D000079:Acetaldehyde / Q000494:pharmacology; D000085:Acetates / Q000494:pharmacology; D000273:Adipose Tissue / Q000187:drug effects / Q000378:metabolism*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D000431:Ethanol / Q000008:administration & dosage / Q000494:pharmacology; D005230:Fatty Acids, Nonesterified / Q000378:metabolism*; D005459:Fluorides / Q000008:administration & dosage / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism*; D006221:Halothane / Q000494:pharmacology*; D006845:Hydrocarbons, Fluorinated / Q000008:administration & dosage / Q000494:pharmacology; D066298:In Vitro Techniques; D008297:Male; D008733:Methoxyflurane / Q000494:pharmacology*; D009638:Norepinephrine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D051381:Rats; D013268:Stimulation, Chemical
D000085:Acetates; D005230:Fatty Acids, Nonesterified; D006845:Hydrocarbons, Fluorinated; D008733:Methoxyflurane; D000431:Ethanol; D011433:Propranolol; D000079:Acetaldehyde; D005990:Glycerol; D005459:Fluorides; D006221:Halothane; D009638:Norepinephrine